Category

UF Startup

Panbela Therapeutics, Inc. Completes Enrollment in Its Phase 1b Trial Investigating SBP-101 Combination Therapy for First-Line Metastatic Pancreatic Cancer

Panbela Therapeutics, Inc., formerly Sun Biopharma, a UF startup and clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, has completed patient enrollment in its Phase 1 trial evaluating the safety and tolerability of SBP-101 when used in combination with standard of care agents gemcitabine and nab-paclitaxel for first-line treatment of patients with metastatic pancreatic ductal adenocarcinoma (PDA).

AGTC Goes Mobile to Avoid Clinical Trial Chaos

When leaders of UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC realized how disruptive COVID-19 might become, they developed a plan—several of them, in fact—to minimize clinical chaos.

FLIR Systems Acquires UF Startup Altavian, Inc.

FLIR Systems, Inc., a company specializing in the design and production of thermal imaging cameras, components and imaging sensors, announced that it has acquired UF startup Altavian, Inc., a privately-held manufacturer of small unmanned aerial systems (sUAS) for defense and public safety customers.

AbFero to Receive € 2M Eurostars Funding for Parkinson’s Disease Therapy

AbFero Ltd., a subsidiary of UF startup AbFero Pharmaceuticals, Inc., a privately-held clinical-stage pharmaceutical company dedicated to treating diseases of iron overload, announced the funding of approximately € 2M from EUREKA Eurostars for the development of iron-chelating compounds including their lead agent, SP-420, as a disease-modifying therapy for Parkinson's disease.